General Enquiries
Hikma Pharmaceuticals PLC
1 New Burlington Place,
London
W1S 2HR
Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
Business Development
Hikma Pharmaceuticals LLC
King Abdullah II street
Building 357
P.O. Box 182400
11118 Amman
Jordan
Tel: +962 (6)580 2960
Fax: +962 6 5802962
Email: customers@hikma.com
Investor Relations
Hikma Pharmaceuticals PLC
1 New Burlington Place,
London
W1S 2HR
Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
Email: investors@hikma.uk.com
Sales and Marketing
Hikma Pharmaceuticals LLC
King Abdullah II Street
Building 357
P.O. Box 182400
11118 Amman
Jordan
Tel: +962 (6)580 2960
Fax: +962 6 5802962
Email: customers@hikma.com
Sustainability
Hikma Pharmaceuticals LLC
21 Saleem Bin Hareth Street
Industrial Area
Bayader Wadi El-Seer
P.O. Box 182400
11118 Amman
Jordan
Tel: +962 (6)580 2900
Fax: +962 6 5817102
Email: mediainquiries@hikma.com
Media
Hikma Pharmaceuticals PLC
1 New Burlington Place,
London
W1S 2HR
Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
Email: mediainquiries@hikma.com
Careers
Hikma Pharmaceuticals LLC
21 Saleem Bin Hareth Street
Industrial Area
Bayader Wadi El-Seer
P.O. Box 182400
11118 Amman
Jordan
Tel: +962 (6) 580 2900
Fax:
Email: vacancy@hikma.com
Pharmacovigilance
For Medical Information Enquiries, Complaints and Adverse Drug Experiences please contact:
If you are in the US, and you want to report an event that occurred with a Hikma or West-Ward product, please contact:
us.hikma@primevigilance.com or please call 1.877.845.0689 or 1.800.962.8364.
If you are in Europe, please contact:
portugaleupharmacovigilance@hikma.com
For all other enquires or to report adverse reaction which occurred outside Europe or the United States of America please contact
pharmacovigilance@hikma.com
Shareholder information
Everything you need to manage your shares, including share listings, depositary receipts, share price information, and dividends.
Please note: if you have a question about a medical condition, you should speak to a healthcare professional.